pe 22-28 peptide PE-22-28 is a synthetic derivative of the naturally occurring peptide spadin - PE-22-28peptidebuy PE-22-28 is a relatively short peptide composed of 22 to 28 amino acids Unveiling PE 22-28 Peptide: A Promising Avenue for Neurological Research

PE-22-28peptidereviews The field of neuroscience is continually exploring novel compounds that could offer therapeutic benefits for a range of neurological and psychological conditions. Among these emerging substances, the PE 22-28 peptide has garnered significant attention for its potential applications in areas such as stress resilience, cognitive performance, and pain modulation. This article delves into the current understanding of PE 22-28 peptide, examining its mechanisms, reported benefits, and its role as a research peptidePE 22-28 (7868) by Tocris, Part of Bio-Techne.

Understanding PE 22-28 Peptide: Structure and Mechanism

PE 22-28 peptide is characterized as a relatively short peptide composed of 22 to 28 amino acids. These amino acids are fundamental building blocks that play crucial roles in various biological processesPE 22-28 is a potent inhibitor of potassium channel subfamily K member 2/TREK-1(IC50 = 0.12 nM). In rodent models of ischemia PE 22-28 reduces apoptotic .... Notably, PE 22-28 is a synthetic derivative of the naturally occurring peptide spadin. This relationship is significant as PE 22-28 was used as the core peptide for the design of several analogs in research aimed at enhancing stability and efficacy.

A key aspect of PE 22-28 peptide's action lies in its potent inhibitory effect on a specific ion channel. It is identified as a potent inhibitor of potassium channel subfamily K member 2/TREK-1. The IC50 value for this inhibition is reported to be remarkably low, at 0作者：A Djillani·2019·被引用次数：42—PE 22-28(Table 2, peptide #21) is the shortest, most efficient sequence capable of blocking the TREK-1 channel with higher potency (IC50=0.12 nM versus IC50=40 ....12 nM. This means that PE 22-28 is a TREK-1 inhibitor, with its mechanism of action centering on modulating the activity of this particular channelThis mechanism produces rapid antidepressant-like effects in preclinical models—within 4 days,PE-22-28 significantly increases hippocampal neurogenesisand .... The TREK-1 channel is implicated in various neurological functions, and its inhibition by PE 22-28 is believed to underpin its observed effects.

Potential Benefits and Research Applications

The research surrounding PE 22-28 peptide highlights several promising areas of application. One of the most frequently cited benefits is its potential to mitigate depression. Studies suggest that PE-22-28 appears to possess potential to mitigate depression within a mere few days without adversely impacting other functions governed by the TREK-1 channel. This rapid onset of action is particularly noteworthy when compared to traditional antidepressant drugsPE 22-28 Supplier | CAS 1801959-12-5 - Tocris Bioscience. Furthermore, peptide PE 22-28 helps manage depression and upregulates neurogenesisPE-22-28 is a relatively short peptide composed of 22 to 28 amino acids. These amino acids are the building blocks of proteins and play vital roles in various ....

Neurogenesis, the process of generating new neurons, is a critical area of research for understanding and treating cognitive decline and mood disorders. PE-22-28 significantly increases hippocampal neurogenesis, which is the formation of new neurons in the hippocampus, a brain region vital for learning and memory.PE-22-28 Peptide: Multifaceted Potential & Benefits | Nūūtro In addition to its effects on mood and neurogenesis, PE 22-28 reduces apoptotic death in rodent models of ischemia, suggesting potential applications in stroke recovery and neuroprotection. The peptide has also been investigated for its role in enhancing cognitive health.2023年10月10日—PE-22-28 has exhibited reported enhanced stabilityand is speculated to induce more neurogenic stability, positioning it as a promising ...

PE 22-28 peptide's potential extends to improving stress resilience. By modulating the TREK-1 channel, it may help the brain better cope with stressful stimuli.PE 22-28 | TREK-1抑制剂 Researchers are also exploring its capacity for pain modulation, though this area requires further investigation作者：A Djillani·2019·被引用次数：42—PE 22-28(Table 2, peptide #21) is the shortest, most efficient sequence capable of blocking the TREK-1 channel with higher potency (IC50=0.12 nM versus IC50=40 .... The PE-22-28 peptide has exhibited reported enhanced stability, which is a crucial factor for therapeutic efficacy and formulation.PE-22-28 Peptide: Depression and Neurogenesis Research

Research and Sourcing PE 22-28

The scientific community is actively engaged in studying PE 22-28 peptidePeptide PE-22-28. Its role as a core peptide in developing other spadin analogs underscores its importance in ongoing research.PE 22-28 is a potent inhibitor of potassium channel subfamily K member 2/TREK-1(IC50 = 0.12 nM). In rodent models of ischemia PE 22-28 reduces apoptotic death ... For instance, (A–D) PE 22-28 was used as the representative peptide for testing the specificity of spadin-analogs against various potassium channels, including TREK-2, TRAAK, and TRESKPE 22-28 peptide现货.

For researchers and institutions interested in acquiring this compound, PE 22-28 is available from various suppliers, often with high purity levels, such as 99% Purity (USA Made). The CAS number associated with PE 22-28 peptide is 97145-43-2. It is important to note that PE 22-28 is primarily a research peptide and its use is intended for scientific investigation.

Future Directions and Considerations

While the findings regarding PE 22-28 peptide are encouraging, it is essential to emphasize that much of the current data stems from preclinical studies. Further research, including rigorous clinical trials, is necessary to fully elucidate its safety profile, optimal dosage, and long-term effects in humans作者：A Djillani·2017·被引用次数：38—With the aim to increase again the stability and the efficacy of the peptide we usedPE 22-28 as core peptidefor the design of several analogs.. Understanding how it works in the brain at a deeper molecular level will also be crucial for its therapeutic development.

In summary, the PE 22-28 peptide represents a compelling area of scientific inquiryPE 22-28 Supplier | CAS 1801959-12-5 - Tocris Bioscience. Its ability to inhibit the TREK-1 channel, coupled with its demonstrated potential in promoting neurogenesis and mitigating depression-like symptoms in preclinical models, positions it as a molecule of significant interest for advancing our understanding of neurological health and developing novel therapeutic strategies.